Patent details
EP2061485 Title: EV576 peptides for use in the treatment of Guillain Barré syndrome
Basic Information
- Publication number:
- EP2061485
- PCT Application Number:
- PCT/GB/2007/003401
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078041993
- PCT Publication Number:
- WO/2008/029167
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- EV576 peptides for use in the treatment of Guillain Barré syndrome
- French Title of Invention:
- Peptides de EV576 pour son utilisation dans le traitement du Syndrome de Guillain-Barré
- German Title of Invention:
- EV576 Peptide zur Verwendung bei der Behandlung des Guillain-Barré-Syndroms
- SPC Number:
Dates
- Filing date:
- 10/09/2007
- Grant date:
- 22/08/2012
- EP Publication Date:
- 22/08/2012
- PCT Publication Date:
- 13/03/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/05/2009
- EP B1 Publication Date:
- 22/08/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/09/2013
- Expiration date:
- 10/09/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/09/2007
- Name:
- Varleigh Immuno Pharmaceuticals (VIP) Ltd
- Address:
- Landmark Fiduciaire (Suisse) SA 6 Place des Eaux-Vives Cas, 1211 Geneva 3, Switzerland (CH)
Inventor
- Name:
- HAMER John
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0617734
- Priority Date:
- 08/09/2006
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 38/17;
| Filing date | Document type | Number of pages |
|---|